A class of diabetes medications may reduce the risk of colorectal cancer

A groundbreaking study by researchers at Case Western Reserve University suggests a class of medications used to treat type 2 diabetes may also reduce the risk of colorectal cancer (CRC).

MGMA: Docs ‘Defy Gravity’ of Inflation, Staff Shortages by Working Harder

Though practice costs for labor and medical equipment have been rising rapidly with inflation, clinicians saw an increase in compensation last year, not because they’re

May 30, 2024

Should Cannabinoids Be Given to Kids With Cancer?

While cannabis-based products have become more popular for symptom management among children with cancer, evidence is lacking on the dosing, safety, and efficacy of cannabinoids

September 1, 2023

UH’s SUSTAIN Center makes lasting impact in the fight against HIV epidemic in Southern U.S.

The SUSTAIN Wellbeing COMPASS Coordinating Center of the University of Houston Graduate College of Social Work has made a lasting impact in the fight against

October 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.